Is immunotherapy the holy grail for pancreatic cancer?

被引：9

作者：

Andersson, Roland ^{[1
,2
]}

Pereira, Carlos-Filipe ^{[3
,4
]}

Bauden, Monika ^{[1
,2
]}

Ansari, Daniel ^{[1
,2
]}

机构：

[1] Lund Univ, Dept Surg, Clin Sci Lund, Lund, Sweden

[2] Skane Univ Hosp, Lund, Sweden

[3] Lund Univ, Lund Stem Cell Ctr, Mol Med & Gene Therapy, BMC A12, S-22184 Lund, Sweden

[4] Lund Univ, Wallenberg Ctr Mol Med, Lund, Sweden

来源：

IMMUNOTHERAPY | 2019年 / 11卷 / 17期

关键词：

biomarkers; immune checkpoint inhibitor; immunotherapy; pancreatic cancer; tumor antigenicity; CLASS-I; INJECTION; ONYX-015;

D O I：

10.2217/imt-2019-0164

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1435 / 1438

页数：4

共 31 条

[1] Pancreatic cancer: yesterday, today and tomorrow [J].

Ansari, Daniel ;

Tingstedt, Bobby ;

Andersson, Bodil ;

Holmquist, Fredrik ;

Sturesson, Christian ;

Williamsson, Caroline ;

Sasor, Agata ;

Borg, David ;

Bauden, Monika ;

Andersson, Roland .

FUTURE ONCOLOGY, 2016, 12 (16) :1929-1946

[2] Genomic analyses identify molecular subtypes of pancreatic cancer [J].

Bailey, Peter ;

Chang, David K. ;

Nones, Katia ;

Johns, Amber L. ;

Patch, Ann-Marie ;

Gingras, Marie-Claude ;

Miller, David K. ;

Christ, Angelika N. ;

Bruxner, Tim J. C. ;

Quinn, Michael C. ;

Nourse, Craig ;

Murtaugh, L. Charles ;

Harliwong, Ivon ;

Idrisoglu, Senel ;

Manning, Suzanne ;

Nourbakhsh, Ehsan ;

Wani, Shivangi ;

Fink, Lynn ;

Holmes, Oliver ;

Chin, Vencssa ;

Anderson, Matthew J. ;

Kazakoff, Stephen ;

Leonard, Conrad ;

Newell, Felicity ;

Waddell, Nick ;

Wood, Scott ;

Xu, Qinying ;

Wilson, Peter J. ;

Cloonan, Nicole ;

Kassahn, Karin S. ;

Taylor, Darrin ;

Quek, Kelly ;

Robertson, Alan ;

Pantano, Lorena ;

Mincarelli, Laura ;

Sanchez, Luis N. ;

Evers, Lisa ;

Wu, Jianmin ;

Pinese, Mark ;

Cowley, Mark J. ;

Jones, Marc D. ;

Colvin, Emily K. ;

Nagrial, Adnan M. ;

Humphrey, Emily S. ;

Chantrill, Lorraine A. ;

Mawson, Amanda ;

Humphris, Jeremy ;

Chou, Angela ;

Pajic, Marina ;

Scarlett, Christopher J. .

NATURE, 2016, 531 (7592) :47-+

[3] Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer [J].

Balachandran, Vinod P. ;

Luksza, Marta ;

Zhao, Julia N. ;

Makarov, Vladimir ;

Moral, John Alec ;

Remark, Romain ;

Herbst, Brian ;

Askan, Gokce ;

Bhanot, Umesh ;

Senbabaoglu, Yasin ;

Wells, Daniel K. ;

Cary, Charles Ian Ormsby ;

Grbovic-Huezo, Olivera ;

Attiyeh, Marc ;

Medina, Benjamin ;

Zhang, Jennifer ;

Loo, Jennifer ;

Saglimbeni, Joseph ;

Abu-Akeel, Mohsen ;

Zappasodi, Roberta ;

Riaz, Nadeem ;

Smoragiewicz, Martin ;

Kelley, Z. Larkin ;

Basturk, Olca ;

Goenen, Mithat ;

Levine, Arnold J. ;

Allen, Peter J. ;

Fearon, Douglas T. ;

Merad, Miriam ;

Gnjatic, Sacha ;

Iacobuzio-Donahue, Christine A. ;

Wolchok, Jedd D. ;

DeMatteo, Ronald P. ;

Chan, Timothy A. ;

Greenbaum, Benjamin D. ;

Merghoub, Taha ;

Leach, Steven D. .

NATURE, 2017, 551 (7681) :512-+

[4] Defective HLA class I antigen processing machinery in cancer [J].

Cai, Lei ;

Michelakos, Theodoros ;

Yamada, Teppei ;

Fan, Song ;

Wang, Xinhui ;

Schwab, Joseph H. ;

Ferrone, Cristina R. ;

Ferrone, Soldano .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (06) :999-1009

[5] Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival [J].

Danilova, Ludmila ;

Ho, Won Jin ;

Zhu, Qingfeng ;

Vithayathil, Teena ;

De Jesus-Acosta, Ana ;

Azad, Nilofer S. ;

Laheru, Daniel A. ;

Fertig, Elena J. ;

Anders, Robert ;

Jaffee, Elizabeth M. ;

Yarchoan, Mark .

CANCER IMMUNOLOGY RESEARCH, 2019, 7 (06) :886-895

[6]

Datta Meenal, 2019, Am Soc Clin Oncol Educ Book, V39, P165, DOI 10.1200/EDBK_237987

[7] Targeting dendritic cells in pancreatic ductal adenocarcinoma [J].

Deicher, Anton ;

Andersson, Roland ;

Tingstedt, Bobby ;

Lindell, Gert ;

Bauden, Monika ;

Ansari, Daniel .

CANCER CELL INTERNATIONAL, 2018, 18

[8] The urgent need to recover MHC class I in cancers for effective immunotherapy [J].

Garrido, Federico ;

Aptsiauri, Natalia ;

Doorduijn, Elien M. ;

Garcia Lora, Angel M. ;

van Hall, Thorbald .

CURRENT OPINION IN IMMUNOLOGY, 2016, 39 :44-51

[9] Improving cancer immunotherapy through nanotechnology [J].

Goldberg, Michael S. .

NATURE REVIEWS CANCER, 2019, 19 (10) :587-602

[10] The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy [J].

Havel, Jonathan J. ;

Chowell, Diego ;

Chan, Timothy A. .

NATURE REVIEWS CANCER, 2019, 19 (03) :133-150

← 1 2 3 4 →